Statement by N.C. Dept. of State Treasurer Folwell, CPA on Food and Drug Administration Approval of New Weight-Loss Drug
November 09, 2023
November 09, 2023
RALEIGH, North Carolina, Nov. 9 -- North Carolina State Treasurer Dale R. Folwell issued the following statement on Nov. 8, 2023:
* * *
Today, the federal Food and Drug Administration (FDA) approved the first GIP/GLP-1 called "Zepbound" for the purpose of weight loss. The drug is manufactured by Eli Lily and contains tirzepatide, the same active ingredient already present in an existing medication called Mounjaro. The State Health Plan (SHP) added Mounjaro to . . .
* * *
Today, the federal Food and Drug Administration (FDA) approved the first GIP/GLP-1 called "Zepbound" for the purpose of weight loss. The drug is manufactured by Eli Lily and contains tirzepatide, the same active ingredient already present in an existing medication called Mounjaro. The State Health Plan (SHP) added Mounjaro to . . .